NBC Securities’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.4K Sell
1,162
-160
-12% -$5.57K ﹤0.01% 1326
2026
Q1
$45.4K Sell
1,322
-3
-0.2% -$102 ﹤0.01% 1356
2025
Q4
$43.6K Buy
1,325
+329
+33% +$10.3K ﹤0.01% 1413
2025
Q3
$28.4K Hold
996
﹤0.01% 1573
2025
Q2
$25K Sell
996
-79
-7% -$2K ﹤0.01% 1606
2025
Q1
$29K Buy
1,075
+1,070
+21,400% +$29.6K ﹤0.01% 1337
2024
Q4
$147 Sell
5
-5,531
-100% -$155K 0.01% 841
2024
Q3
$159K Sell
5,536
-611
-10% -$17.5K 0.01% 855
2024
Q2
$167K Sell
6,147
-65
-1% -$1.74K 0.02% 810
2024
Q1
$174K Sell
6,212
-119
-2% -$3.28K 0.02% 796
2023
Q4
$168K Sell
6,331
-28
-0.4% -$706 0.02% 795
2023
Q3
$162K Buy
+6,359
New +$168K 0.02% 769

Other funds holding FTXH

NBC Securities's FTXH Position: Q2 2026 in Review

NBC Securities reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 12% in Q2 2026, selling an estimated $5.57K and leaving 1,162 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1326.

NBC Securities first reported a position in FTXH in Q3 2023 and has held it in 12 quarters since. The position peaked at $174K in Q1 2024. 8 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

  • NBC Securities held 1,162 shares of First Trust Nasdaq Pharmaceuticals ETF worth $44.4K as of Q2 2026.
  • NBC Securities sold 160 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $5.57K.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1326 holding.
  • NBC Securities first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's First Trust Nasdaq Pharmaceuticals ETF position peaked at $174K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.